Immunocore

Immunocore

Primary Menu

  • About us
    • Management Team
    • Board of Directors
    • Partners
    • Compliance and Transparency
  • Our science
    • Pipeline
    • Publications
  • Our therapy areas
    • Oncology
    • Infectious Diseases
    • Autoimmune and Inflammation Diseases
  • Our products
  • For patients
  • Investors/Media
  • News
  • Careers
  • Contact us

Primary Menu

  • About us
  • Our science
  • Our therapy areas
  • Our products
  • For patients
  • Investors/Media
  • News
  • Careers
  • Contact us

Our science

We have a robust pipeline of wholly owned and partnered programmes to address a broad spectrum of disease indications.

Read more
  • Pipeline
  • Publications
  • Scientific Advisory Board

Our focus

Our foundation is built on our proprietary soluble TCR bi-specific ImmTAC® platform.

Read more
  • Oncology
  • Infectious Diseases
  • Autoimmune and Inflammation Diseases
Our clinical trials

Immunocore

Immunocore
  • About us
  • Our science
  • Our therapy areas
  • Our products
  • For patients
  • Investors/Media
  • Careers
  • Contact us
  • Privacy and Social Media Guidelines
  • Cookies
  • Payments and Disclosures
  • Clinical trials
  • Gender Pay Report
  • Modern Slavery Statement

©2023 Immunocore Ltd. All rights reserved. Immunocore, ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all trademarks of Immunocore Ltd